Effect of a Low-carbohydrate, High-protein Energy-restricted Diet on Weight and Body Composition Using DXA
Primary Purpose
Weight Loss, Body Composition
Status
Unknown status
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
High Protein Diet Group
No High Protein Diet Group
Sponsored by
About this trial
This is an interventional treatment trial for Weight Loss
Eligibility Criteria
Inclusion Criteria:
- individuals between the ages of 20 and 30
- who were not currently consuming any drugs or were on diet or exercise treatment.
- patients must have 120% or more of the ideal weight until a BMI of 35.
Exclusion Criteria:
- with no cardiovascular disease, kidney, intestinal or liver disease.
- cholesterol (≥ 200 mg/dL)
- high triglycerides (≥ 150mg/dL)
- glucose (≥ 126mg /dL)
Sites / Locations
- Facultad de Organización Deportiva, FOD, Universidad Autónoma de Nuevo León
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
High Protein Diet Group
No High Protein Diet Group
Arm Description
The high protein diet (HPD) group is instructed to follow a low carbohydrate, high protein ketogenic diet.
No high protein diet (NHPD) group received an oat beverage consisted of 55 g of oats in 250 ml of water.
Outcomes
Primary Outcome Measures
Body fat
Body fat measurements by DXA
Lean mass
Lean mass measurements by DXA
Weight lost
Weight lost through the various phases
Secondary Outcome Measures
Body water
Body water changes measured by bioelectrical impedance
Resting energy expenditure
Energy expenditure measure by calorimetry.
Caloric and macronutrient intake
Energy and macronutrient distribution intake. To estimate the nutrient intake is used as a weighted dietary record. Each individual weighs the items on a scale before and after consumption by three consecutive days. Scales has a precision of 1 g. The persons record all the food and beverages consumed, including ingredients, preparation method, and quantity of the food consumed and not consumed. We proportionate all the instruction and description for the individual before assigning the task to record. This procedure ensures the accuracy and reliability of the information provided. Records are processed with the software DietOrganizer (R) to obtain caloric and macronutrient intake.
Serum fasting triglycerides
Serum fasting triglicerides are taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Serum fasting glucose
Serum fasting glucose is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Serum fasting total cholesterol
Serum total cholesterol is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Serum fasting HDL cholesterol
Serum total cholesterol is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Serum fasting albumin
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
Serum fasting total protein
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
Serum fasting total hemoglobin
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
hand strenght with a dynamometer
Hand strength is measured with a standardized protocol using a chair. A digital dynamometer is employed, and units are expressed as kg.
triceps skinfold with a plicometer
triceps skinfold is measured with a plicometer and the units are expresed as mm
waist perimeter
waist perimeter is measured with a measuring tape and units are expresed as cm
mid-arm perimeter
mid arm perimeter is measured with a measuring tape and units are expresed as cm
Full Information
NCT ID
NCT04646733
First Posted
November 13, 2020
Last Updated
November 23, 2020
Sponsor
Erik Ramirez Lopez
1. Study Identification
Unique Protocol Identification Number
NCT04646733
Brief Title
Effect of a Low-carbohydrate, High-protein Energy-restricted Diet on Weight and Body Composition Using DXA
Official Title
Effect of a Low-carbohydrate, High-protein Ketogenic Diet on Weight and Body Composition: a Randomized Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Unknown status
Study Start Date
January 13, 2020 (Actual)
Primary Completion Date
May 9, 2020 (Actual)
Study Completion Date
April 29, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Erik Ramirez Lopez
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
People often choose certain diets to lose weight or to change their habits or lifestyle. The Dukan diet was created in the '70s and took on importance in the last decade. It is a 4 phase diet similar to the Atkins diet. However, this diet is aggressive in its first phase because it suppresses carbohydrates, the main source of external energy being saturated low-fat protein. Studies of this diet are scarce and have been limited to describing the contribution of micronutrients. In nutritional practice, it is often assumed that a popular high-protein or low-calorie ketogenic diet could cause rapid or unfavourable changes in a patient's weight and body composition. However, the effect of these diets in the short or long term on weight and on body fat, muscle mass and other components is not clear. This means that body composition has not been the main objective when analyzing the effect of a popular diet. For this reason, the meta-analyzes focus on weight change and the absence of body composition data is a limitation of the selected studies. Changes in body composition due to a popular diet should be evaluated with techniques such as DXA. The aim of this study is to analyze the effect of a low-carbohydrate, high-protein diet with energy restriction on weight and body composition using DXA. For this, a randomized controlled study will be used where a group will receive the diet protocol. The control group will have a normal diet, and only one oatmeal drink will be added (55 g of oats in 250 ml of water). The drink will contain 1.6 g of BetaG per serving according to FDA recommendations that correspond to the 50% BetaG required per day.
Detailed Description
The patients (n = 60) are invited through posters and social networks to recruit a group of 40 overweight subjects (20% above their ideal weight). The protocol is explained in detail to each one, and the patient and two witnesses sign the informed consent. Subjects are assigned to one of two groups: group A: high protein diet (HPD) and group B: non-high protein diet (NHPD). The NHPD is designed according to Mexican nutrition guidelines according to sex and age.
The main anthropometric and biochemical measurements and diet monitoring are performed in the body composition laboratory of the Faculty of Sports Organization (FOD). Four technicians (nutritionists) are in charge of taking the measurements and recording the data. The principal investigators review the quality of the information and the correct completion of the records. Each file will be assigned an identification number. Other nutritionists (graduate students) will be in charge of auditing the information according to the protocol guidelines. Principal Investigators will resolve any discrepancies between technicians and graduate students to ensure data recording, deletion, or reevaluation.
Each patient is asked for a prior medical examination before entering the study. The data from the external medical practitioner are compared with those provided by the patient for the present study.
The main anthropometric variables are measured with the international ISAK methodology. The DXA equipment is calibrated daily, and the result is analyzed and analyzed by a researcher who evaluates whether the measurement is reliable.
The data is recorded in printed formats that are immediately scanned to maintain readability. Later, they are recorded in an Excel sheet with the patient's identification number. In each measurement session, the database is analyzed for abnormal, extreme or unlikely data. Two independent researchers are responsible for reviewing the database every day.
Each patient is cared for by a nutrition student who accompanies him in the basic needs, clothing and transfers to the measurement equipment. At the end of the evaluation, patients receive a complimentary meal and free transportation home.
Patients are monitored through WhatsApp to verify the presence of adverse events with the diet. Also, for any questions with the procedures. All procedures are recorded in paper and electronic form. In addition, they are given an additional number in case of medical emergency or consultation with a nutritionist.
The sample size will be limited in the first stage to 30 patients. Measurements and preliminary analysis will be obtained at 0, day four and day fifteen. The last two measurements will be taken on day 42 and until the subjects reach their ideal body weight.
In the case of missing data or defective quality record, subjects will be removed.
Regarding the statistical analysis, multiple linear regression will be used, where the groups and measurements will be compared on the different measurement days. As covariates, covariates will be incorporated as initial values, age, sex, BMI, among others, will be adjusted. Descriptive statistics will be added.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Loss, Body Composition
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a randomized controlled clinical study. Subjects are assigned to one of two groups: the intervention group (group A or high protein diet or HPD) and the group without high protein diet or NHPD. The assignment is done with the use of MedCalc software and the option to create random groups. Both groups are treated equally except for the procedure or diet. The blind or double-blind procedure is not used in this study. Both groups are treated during the same study period. The maximum number of patients to be evaluated per day will be three. Patients are not mixed from one group or another in each evaluation.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
High Protein Diet Group
Arm Type
Experimental
Arm Description
The high protein diet (HPD) group is instructed to follow a low carbohydrate, high protein ketogenic diet.
Arm Title
No High Protein Diet Group
Arm Type
Active Comparator
Arm Description
No high protein diet (NHPD) group received an oat beverage consisted of 55 g of oats in 250 ml of water.
Intervention Type
Other
Intervention Name(s)
High Protein Diet Group
Intervention Description
The high protein diet (HPD) group is instructed to follow a low carbohydrate, high protein ketogenic diet. This diet has 4 phases, two of weight loss until reaching the ideal weight (attack and cruise) and two of maintenance (consolidation and stabilization). During the first 2 phases, it allows 100 foods (28 vegetables). The first phase lasts 3-10 days and 72 high-protein, low-fat foods are allowed. In the second phase, there are alternate days between consuming the low glycemic index vegetables plus protein and the next day with just protein. The first two phases are ad libitum. Phase 3 (consolidation) aims to avoid rebound and begins the introduction of complex carbohydrates and legumes in individual servings. In phase 4 (stabilization), the subject returns to a free diet. However, three basic rules are introduced: protein one day a week, the exercise of at least 20 min/day (optional) and consumption of 3 tablespoons of oat bran/day.
Intervention Type
Other
Intervention Name(s)
No High Protein Diet Group
Intervention Description
No high protein diet (NHPD) group received an oat beverage consisted of 55 g of oats in 250 ml of water. Beverage contained 1.6 g of betaG per portion according to FDA recommendations corresponding to 50 % of betaG required per day. Weekly bags containing oat mixture were provided on day 0 and in the third week of the trial. No additional instructions about diet, exercise program or pharmacological treatment was implemented.
Primary Outcome Measure Information:
Title
Body fat
Description
Body fat measurements by DXA
Time Frame
Baseline to three months.
Title
Lean mass
Description
Lean mass measurements by DXA
Time Frame
Baseline to three months
Title
Weight lost
Description
Weight lost through the various phases
Time Frame
Baseline to three months
Secondary Outcome Measure Information:
Title
Body water
Description
Body water changes measured by bioelectrical impedance
Time Frame
Baseline to three months
Title
Resting energy expenditure
Description
Energy expenditure measure by calorimetry.
Time Frame
Baseline to three months
Title
Caloric and macronutrient intake
Description
Energy and macronutrient distribution intake. To estimate the nutrient intake is used as a weighted dietary record. Each individual weighs the items on a scale before and after consumption by three consecutive days. Scales has a precision of 1 g. The persons record all the food and beverages consumed, including ingredients, preparation method, and quantity of the food consumed and not consumed. We proportionate all the instruction and description for the individual before assigning the task to record. This procedure ensures the accuracy and reliability of the information provided. Records are processed with the software DietOrganizer (R) to obtain caloric and macronutrient intake.
Time Frame
Baseline to three months
Title
Serum fasting triglycerides
Description
Serum fasting triglicerides are taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Time Frame
Baseline to three months
Title
Serum fasting glucose
Description
Serum fasting glucose is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Time Frame
Baseline to three months
Title
Serum fasting total cholesterol
Description
Serum total cholesterol is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Time Frame
Baseline to three months
Title
Serum fasting HDL cholesterol
Description
Serum total cholesterol is taken after 9 to 12 h, milligrams per deciliter (mg/dL).
Time Frame
Baseline to three months
Title
Serum fasting albumin
Description
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
Time Frame
Baseline to three months
Title
Serum fasting total protein
Description
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
Time Frame
Baseline to three months
Title
Serum fasting total hemoglobin
Description
Serum total cholesterol is taken after 9 to 12 h, grams per deciliter (g/dL).
Time Frame
Baseline to three months
Title
hand strenght with a dynamometer
Description
Hand strength is measured with a standardized protocol using a chair. A digital dynamometer is employed, and units are expressed as kg.
Time Frame
Baseline to three months
Title
triceps skinfold with a plicometer
Description
triceps skinfold is measured with a plicometer and the units are expresed as mm
Time Frame
Baseline to three months
Title
waist perimeter
Description
waist perimeter is measured with a measuring tape and units are expresed as cm
Time Frame
Baseline to three months
Title
mid-arm perimeter
Description
mid arm perimeter is measured with a measuring tape and units are expresed as cm
Time Frame
Baseline to three months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
33 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
individuals between the ages of 20 and 30
who were not currently consuming any drugs or were on diet or exercise treatment.
patients must have 120% or more of the ideal weight until a BMI of 35.
Exclusion Criteria:
with no cardiovascular disease, kidney, intestinal or liver disease.
cholesterol (≥ 200 mg/dL)
high triglycerides (≥ 150mg/dL)
glucose (≥ 126mg /dL)
Facility Information:
Facility Name
Facultad de Organización Deportiva, FOD, Universidad Autónoma de Nuevo León
City
Monterrey
State/Province
N.l.
ZIP/Postal Code
64460
Country
Mexico
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28758964
Citation
Anton SD, Hida A, Heekin K, Sowalsky K, Karabetian C, Mutchie H, Leeuwenburgh C, Manini TM, Barnett TE. Effects of Popular Diets without Specific Calorie Targets on Weight Loss Outcomes: Systematic Review of Findings from Clinical Trials. Nutrients. 2017 Jul 31;9(8):822. doi: 10.3390/nu9080822.
Results Reference
background
PubMed Identifier
25387778
Citation
Atallah R, Filion KB, Wakil SM, Genest J, Joseph L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. Long-term effects of 4 popular diets on weight loss and cardiovascular risk factors: a systematic review of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):815-27. doi: 10.1161/CIRCOUTCOMES.113.000723. Epub 2014 Nov 11.
Results Reference
background
PubMed Identifier
31726791
Citation
Seid H, Rosenbaum M. Low Carbohydrate and Low-Fat Diets: What We Don't Know and Why we Should Know It. Nutrients. 2019 Nov 12;11(11):2749. doi: 10.3390/nu11112749.
Results Reference
background
Learn more about this trial
Effect of a Low-carbohydrate, High-protein Energy-restricted Diet on Weight and Body Composition Using DXA
We'll reach out to this number within 24 hrs